SMT Iberia

What SMT Iberia does

SMT Iberia is the Iberian Peninsula regional operation of Sahajanand Medical Technologies (SMT), an Indian-founded cardiovascular medical device company established in 2001 and headquartered in India. The Iberia entity operates from Paterna, Valencia, with a 7-person team, and is part of a global commercial network spanning Spain, Germany, Poland, Australia, New Zealand, China, the United States, and India. SMT Iberia sells directly to hospitals, cardiology departments, and interventional cardiologists rather than operating a separate manufacturing facility.

SMT's product portfolio is organized into four device categories: coronary intervention (drug-eluting stent systems including Supraflex Cruz, Supraflex, Tetriflex, Tetrilimus, Supraflex Star, Flexinnium, and Everoflex, plus PTCA balloon dilatation catheters Wilma SC/NC and Pipit SC/NC); structural heart (Hydra transcatheter aortic valve for TAVI and the Cocoon family of septal, PFO, duct, and VSD occluders); peripheral intervention (Renofit balloon-expandable renal/biliary stent and Peripherics drug-coated PTA balloon); and procedural accessories (SMT i30 inflation device, Identity aspiration catheter, Easy-Catch+ haemostatic Y connector). The portfolio is supported by clinical evidence generated through the TALENT randomized controlled trial for Supraflex and by professional-education content distributed via the SMT Channel YouTube platform, which broadcasts live case transmissions from leading international hospitals.

The business model is B2B hardware sales of cardiovascular implants to healthcare providers via enterprise field-sales representatives and regionally embedded commercial teams. Pricing is quote-based and negotiated directly with hospitals and tender frameworks, with no public pricing. The company is in the process of transitioning from private to public status, having filed with SEBI in 2024 for an Initial Public Offer, and has built out investor-relations, corporate-governance, and financial-disclosure infrastructure consistent with that trajectory. Distribution is direct rather than through third-party distributors, and brand building relies on conference participation (Euro PCR, India Live), KOL engagement, and clinical-evidence publication rather than paid advertising.

Name

SMT Iberia

Legal name

Sahajanand Medical Technologies Pvt. Ltd.

Website

https://es.smtpl.com

Company type

Public

Founded year

2001

Operating status

Operating

Headcount range

1–10 employees

Short description

SMT Iberia is the Spanish regional operation of Sahajanand Medical Technologies, selling minimally invasive cardiovascular devices — drug-eluting stents, PTCA balloons, TAVI valves, and occluders — directly to hospitals and interventional cardiologists across the Iberian Peninsula.

Ownership category

akta.pro rank

Product category

Cardiovascular Medical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Structural Heart Valves (TAVR/SAVR) & Valve Repair (HLAHAFAB)

akta.pro secondary industry

Interventional Cardiology (PCI/Structural Heart) (HLAKABAB)

Keywords

• Cardiovascular medical devices
• Drug-eluting stents
• Interventional cardiology
• Structural heart devices
• Peripheral intervention devices

Headquarters

HQ city

Not specified

HQ country

Spain

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Medical Device Sales: SMT generates revenue through the sale of cardiovascular medical devices including coronary stents, balloon catheters, structural heart valves, and occluder devices to hospitals and healthcare providers globally.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

SMT Iberia distributes and supports a portfolio of minimally invasive cardiovascular medical devices manufactured by parent Sahajanand Medical Technologies. Offerings include drug-eluting coronary stents, PTCA balloon dilatation catheters, the Hydra transcatheter aortic valve for TAVI, Cocoon occluder devices for congenital heart defects, peripheral intervention products, and procedural accessories sold to hospitals and interventional cardiology departments across Spain.

Product overview

SMT is a leading global developer and manufacturer of minimally invasive cardiovascular medical devices. The company offers a comprehensive portfolio organized into four main product categories: Coronary Intervention devices (including drug-eluting stents such as Supraflex Cruz, Supraflex, Tetriflex, Tetrilimus, Supraflex Star, Flexinnium, Everoflex, and PTCA balloon catheters Wilma SC/NC, Pipit SC/NC), Structural Heart Devices (Hydra Aortic Valve for TAVI and occluder devices including Cocoon Septal, PFO, Duct, and VSD Occluders), Peripheral Intervention Devices (Renofit balloon expandable stent and Peripherics drug-coated PTA balloons), and Accessories (SMT i30 Inflation Device, Identity Aspiration Catheter, Easy-Catch+ Haemostatic Y Connector). The products work together to enable minimally invasive treatment of cardiovascular conditions including coronary artery disease, peripheral artery disease, and congenital heart defects.

Differentiator

Problem solved

Functional benefit

Brands

• Supraflex Cruz: Drug-eluting coronary stent system
• Supraflex
• Tetriflex
• Tetrilimus
• Hydra Aortic Valve
• Cocoon Septal Occluder
• Cocoon PFO Occluder
• Cocoon Duct Occluder
• Cocoon VSD Occluder
• Renofit
• Peripherics

Products and services

• Supraflex Cruz Drug-Eluting Coronary Stent Drug-eluting coronary stent system designed for complex lesion treatment with advanced deliverability and flexibility; sold to hospitals and interventional cardiologists.
• Tetriflex Coronary Stent System Drug-eluting coronary stent system for coronary intervention procedures; sold to hospitals and interventional cardiologists.
• Tetrilimus Coronary Stent System Drug-eluting coronary stent system for coronary intervention procedures; sold to hospitals and interventional cardiologists.
• Supraflex Star Coronary Stent System Drug-eluting coronary stent system variant for coronary intervention procedures; sold to hospitals and interventional cardiologists.
• Wilma SC PTCA Balloon Dilatation Catheter Semi-compliant PTCA balloon dilatation catheter used in coronary interventions; sold to hospitals and interventional cardiologists.
• Wilma NC PTCA Balloon Dilatation Catheter Non-compliant PTCA balloon dilatation catheter used in coronary interventions; sold to hospitals and interventional cardiologists.
• Pipit SC PTCA Balloon Dilatation Catheter Semi-compliant PTCA balloon dilatation catheter for coronary interventions; sold to hospitals and interventional cardiologists.
• Pipit NC PTCA Balloon Dilatation Catheter Non-compliant PTCA balloon dilatation catheter for coronary interventions; sold to hospitals and interventional cardiologists.
• Hydra Aortic Valve (TAVI Device) Transcatheter aortic valve implantation device for treating aortic stenosis; sold to hospitals and cardiac surgery/interventional cardiology teams.
• Cocoon Septal Occluder Occluder device for closing atrial septal defects (ASD); sold to hospitals and interventional cardiologists.
• Cocoon PFO Occluder Occluder device for closing patent foramen ovale (PFO); sold to hospitals and interventional cardiologists.
• Cocoon Duct Occluder Occluder device for closing patent ductus arteriosus (PDA); sold to hospitals and interventional cardiologists.
• Cocoon VSD Occluder Occluder device for closing ventricular septal defects (VSD); sold to hospitals and interventional cardiologists.
• Renofit Balloon Expandable Renal and Biliary Stent System Balloon expandable renal and biliary stent system for peripheral artery disease treatment; sold to hospitals and interventional radiologists/cardiologists.
• Peripherics Drug-Coated PTA Balloon Drug-coated PTA balloon for peripheral interventions; sold to hospitals and interventional specialists.
• SMT i30 Inflation Device Inflation device accessory used in balloon catheter procedures; sold to hospitals and interventional cardiology departments.
• Identity Aspiration Catheter Aspiration catheter used for thrombectomy and clot removal procedures; sold to hospitals and interventional cardiology departments.
• Easy-Catch+ Haemostatic Y Connector Haemostatic Y connector for interventional cardiology procedures; sold to hospitals and interventional cardiology departments.

Named customers4 records

Segments3 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators1 record

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Medtronic: Medtronic competes directly with SMT in coronary stents (Resolute), balloon catheters and TAVI (Evolut). Its scale, clinical evidence base and global salesforce make it a primary benchmark competitor.
• B. Braun: B. Braun's Aesculap division sells cardiovascular intervention devices including coronary stents and balloons, overlapping with SMT's coronary portfolio in European markets like Spain and Germany.
• Terumo: Terumo competes with SMT across interventional cardiology including PTCA balloons, DES and accessory devices, with significant European and emerging-market presence.
• Boston Scientific: Boston Scientific is a direct competitor in drug-eluting stents (Promus/Synergy) and structural heart, with strong European commercial coverage that overlaps with SMT Iberia's geography.
• Abbott Vascular: Abbott's vascular division is a global leader in drug-eluting stents (Xience), balloon catheters and structural heart devices. It is the most direct large incumbent against SMT across the coronary and structural heart portfolio.

Direct peers

• Edwards Lifesciences: Edwards is the global TAVI market leader (Sapien platform) and the most direct competitor to SMT's Hydra transcatheter aortic valve, particularly in Spain and broader Europe.
• Meril Life Sciences: Indian-headquartered cardiovascular device manufacturer with a comparable portfolio of stents, balloon catheters and structural heart devices; the closest emerging-market peer to SMT and a direct competitor in emerging geographies.

Emerging players

• MicroPort Scientific: MicroPort's cardiovascular division offers coronary stents (Firehawk/Firebird) and structural heart devices with global ambitions similar to SMT's, including presence in Europe and emerging markets.
• Translumina Therapeutics: India-based drug-eluting stent specialist with overlap in coronary intervention products and European distribution, directly competing with SMT in cost-sensitive segments.
• Lepu Medical: Chinese cardiovascular device company with coronary stents, occluders and structural heart products; comparable portfolio breadth and emerging-market positioning to SMT.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/SMTStents
• YouTubeyoutube.com/channel/UCPcg82gwTqgGlD6kQw6gSOg/videos
• Facebookfacebook.com/SMTPL
• LinkedInlinkedin.com/company/smt-iberia

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SMT Iberia